Matthew T. Duvernay

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

Volkan Granit, Michael Benatar, Metin Kurtoğlu et al. · The Lancet Neurology · 2023 · 216 citations · Full text

Allergy, Autoimmune Disease, Non-randomised Phase 1B/2a +6

A Conserved Motif for the Transport of G Protein-coupled Receptors from the Endoplasmic Reticulum to the Cell Surface

Matthew T. Duvernay, Fuguo Zhou, Guangyu Wu · Journal of Biological Chemistry · 2004 · 158 citations · Full text

Protease-Activated Receptor (PAR) 1 and PAR4 Differentially Regulate Factor V Expression from Human Platelets

Matthew T. Duvernay, Summer E. Young, David Gailani et al. · Molecular Pharmacology · 2013 · 73 citations · Full text

The role of coagulation and platelets in colon cancer-associated thrombosis

Annachiara Mitrugno, Samuel Tassi Yunga, Joanna L. Sylman et al. · American Journal of Physiology-Cell Physiology · 2018 · 70 citations · Full text

Immunology, Pathology, Platelet Pathobiology +18

Anterograde Trafficking of G Protein-Coupled Receptors: Function of the C-Terminal F(X)6LL Motif in Export from the Endoplasmic Reticulum

Matthew T. Duvernay, Chunmin Dong, Xiaoping Zhang et al. · Molecular Pharmacology · 2009 · 69 citations · Full text